What patents cover Vijoice (and who owns them)?
“Vijoice” is a brand name used in different markets, so the exact patent set depends on which drug/product you mean (and the country). Patent coverage usually sits with the company that develops and markets the product in that jurisdiction, and patent families can include different claims for the active ingredient, specific formulations, manufacturing methods, and related uses.
Which Vijoice patent should you look up (ingredient, formulation, or use)?
If you want the most relevant patent(s), start from the exact product definition used by regulators and payers in your country:
- the active ingredient and strength
- dosage form (for example, oral vs. injection)
- any named therapeutic indication
- the marketing authorization holder
Patents tied to other versions (different strengths, salt forms, or indications) may be separate and won’t control generic/biosimilar entry for your specific Vijoice product.
When does a Vijoice patent expire (and what delays exclusivity)?
Patent expiry depends on the filing date and local patent term rules, and exclusivity can also be extended by:
- patent term adjustments/paediatric extensions (jurisdiction-dependent)
- supplementary protection certificates (SPCs) (in some regions)
- regulatory exclusivities (separate from patents)
To answer “when it expires” accurately, you need the country and the exact Vijoice product/active ingredient you’re referring to.
Can generics or biosimilars enter before the Vijoice patent expires?
Whether earlier entry is possible depends on the patent landscape and mechanism:
- Generics can be blocked until key patents or regulatory exclusivity end, but some can launch earlier under carve-outs if they do not infringe specific claims.
- Biosimilar timing is often driven by biologics-specific exclusivity and patent assertions around the molecule and manufacturing.
Are there challenges or court cases about Vijoice patents?
Patent disputes typically show up as:
- pre-grant oppositions or re-examinations (where available)
- infringement actions
- validity/obviousness challenges
- settlements tied to “launch at risk” dates
To confirm whether Vijoice patents are being challenged, you’d need the jurisdiction and the patent numbers or assignees.
How to find the right Vijoice patent quickly (what to search)
Once you know the country and exact drug identity, searches usually work best using:
- brand name (Vijoice) plus active ingredient
- marketing authorization holder / applicant name
- patent family numbers
- INPADOC family data or national patent office registers
If you share the active ingredient (or a link to the product page) and the country you care about, I can help you identify the likely patent family and how to interpret its expiry/exclusivity timing.
What I need from you to give a precise “Vijoice patent” answer
Reply with:
1) the country (e.g., US, UK, EU, India, etc.)
2) the active ingredient in Vijoice (or the exact label/strength/formulation)
3) whether you mean “the patent that blocks generics/biosimilars” or “all patents on the product”
Then I can narrow to the relevant patents and explain their expiry and what they cover.